Facebook
Twitter
LinkedIn

Media Center

FAST, Fellows and CARB-X Update June 2020
Facebook
Twitter
LinkedIn

FAST & Fellows Round-Up

  • Applied Molecular Transport (FAST Spring ’14) announced the closing of its initial public offering. The aggregate total gross proceeds to AMT from the offering were $177.1 million. AMT’s common stock began trading on Nasdaq on June 5, 2020, under the ticker symbol “AMTI.” Read More
  • Pendulum Therapeutics (formerly Whole Biome – FAST Spring 2014) has launched the first medical probiotic for people with type 2 diabetes. Read More
  • Phi Therapeutics (FAST Fall 2017) has launched with its precision microbiome editing products to treat bacterial diseases. Its product line, sold under the name Phyla, is initially targeted on acne. Read More

CARB-X News

  • CARB-X funds Microbion up to $6.1M to develop inhaled drug to treat cystic fibrosis-related lung infections. Read More
  • CARB-X funds Module Innovations up to $702,000 to develop a simple test to diagnose urinary tract infections (UTI) and identify superbugs causing the infection within 2 hours. Read More